GGrantIndex
Sort

46,585 grants matching heart failure

A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction

$664,604
Marc A Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG

A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction

$664,604
Marc A Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG

Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy

$664,596
Joshua M Hare · University Of Miami School Of Medicine · UM1 · FY2014 · HL

Mechanisms of oxygen off-loading from red blood cells in murine models of human disease

$664,584
Walter F Boron · Case Western Reserve University · R01 · FY2022 · HL

Translational Studies in Heart Failure Gene Therapy

$664,559
Charles R Bridges · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · HL

An XFM Interventional Guidance System for Cardiac Resynchronization Therapy

$664,468
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2012 · EB

NF-kB-dependent miRNAs in Cardioprotection and Regeneration

$664,333
W Keith Jones · Loyola University Chicago · R01 · FY2014 · HL

Ambulatory phenotyping with real-time indices of discordant affect regulation: Exploring opportunities for targeted intervention in depression

$664,331
Jonathan P Stange · University Of Southern California · R01 · FY2025 · MH

Lipid Peroxidation-Induced Mitochondrial Injury Inhibits Vascular Function in Single Ventricle Congenital Heart Disease

$664,316
Sushma Reddy · Stanford University · R01 · FY2023 · HL

Vascular Stiffness and Pulmonary Congestion

$664,313
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2007 · HL

Calcium Signaling Mechanisms in Cardiac Fibrogenesis

$664,206
Lixia Yue · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · HL

Deciphering Mechanisms for Triglyceride and Cholesterol Transport

$664,190
Stephen G Young · University Of California Los Angeles · P01 · FY2019 · HL

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

$664,132
Subha V Raman · Ohio State University · R01 · FY2017 · HL

Intervention based in primary care to increase physical activity among inactive adults with prediabetes and diabetes

$664,114
Deborah R Young · Kaiser Foundation Research Institute · R01 · FY2022 · DK

Exploration of Arrhythmogenic Triggers and Substrates in Heart Failure

$664,092
Natalia A. Trayanova · Johns Hopkins University · R01 · FY2018 · HL

4D virtual Catheter (4D vCath) for multi-factorial hemodynamics in pulmonary hypertension

$664,005
Mohammed Elbaz · Northwestern University At Chicago · R01 · FY2025 · HL

Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural Peptides

$663,965
Hector H Valdivia · University Of Wisconsin-Madison · R01 · FY2023 · HL

Integration of structure and signaling in cardiac pacemaker function

$663,956
Vadim V Fedorov · Ohio State University · R01 · FY2021 · HL

Familial Dilated Cardiomyopathy: Detection/Gene Mapping

$663,954
Ray E Hershberger · University Of Miami School Of Medicine · R01 · FY2010 · HL

Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults

$663,944
Vasantha Kolavennu Jotwani · Northern California Institute/Res/Edu · R01 · FY2024 · HL

Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins

$663,909
Tomas G Neilan · Massachusetts General Hospital · R01 · FY2019 · HL

Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients

$663,889
Majid Afshar · University Of Wisconsin-Madison · R01 · FY2020 · DA

Role of Kir4.1 in regulating NCC and ROMK in DCT

$663,882
Wen-Hui Wang · New York Medical College · R01 · FY2023 · DK

Role of Kir4.1 in regulating NCC and ROMK in DCT

$663,882
Wen-Hui Wang · New York Medical College · R01 · FY2025 · DK

Development of a Percutaneous Double Lumen Cannula-Based Cavopulmonary Assist System Toward Clinical Application

$663,863
Dongfang Wang · University Of Kentucky · R01 · FY2024 · HL